← Leaderboards
Ying Lu
University Of California San Francisco
$8,099,746
Attributed
$13,358,608
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2006–25$2.5M$1.9M$1.3M$625K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,358,608 · 9
By mechanism
R33$6,355,802 · 1
P30$2,974,662 · 1
P01$1,565,613 · 3
R61$1,532,491 · 1
R01$683,790 · 1
R03$221,250 · 1
Top collaborators
- Ronald L Dalman5 shared
- Kenneth W. Mahaffey5 shared
Most similar at University Of California San Francisco
Same institution · by research overlap
- Richard C Jordan$12,293,393
- Laura J Esserman$22,971,436
- Frank Patrick McCormick$56,513,144
- Teresa L. Wright$3,215,991
- Scott C Kogan$5,271,284
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchResearch PersonnelProgramsFacultyFundingMonitorMedicalClinical TrialsJournalsDesignStatistical MethodsBaseCostPreventionLaboratoriesMalignant NeoplasmsProductionHuman ResourcesOncologyParticipantCollaborationsGrantCell TherapyBiometry
Grant awards (26)
The LIMIting AAA with meTformin (LIMIT) Trial$1,321,656
R33 · FY2025 · HL
Biostatistics and Data Management$404,349
P01 · FY2025 · CA · contact PI
Stat4Onc Annual Symposium$5,000
R13 · FY2025 · CA · contact PI
The LIMIting AAA with meTformin (LIMIT) Trial$1,576,678
R33 · FY2024 · HL
Stat4Onc Annual Symposium$5,000
R13 · FY2024 · CA · contact PI
The LIMIting AAA with meTformin (LIMIT) Trial$1,728,178
R33 · FY2023 · HL
Core B: Biostatistics and Data Management Core$291,778
P01 · FY2023 · CA · contact PI
Stat4Onc Annual Symposium$5,000
R13 · FY2023 · CA · contact PI
The LIMIting AAA with meTformin (LIMIT) Trial$1,729,290
R33 · FY2022 · HL
Core B: Biostatistics and Data Management Core$285,942
P01 · FY2022 · CA · contact PI
Stat4Onc Annual Symposium$5,000
R13 · FY2022 · CA · contact PI
Core B: Biostatistics and Data Management Core$291,778
P01 · FY2021 · CA · contact PI
Stat4Onc Annual Symposium$5,000
R13 · FY2021 · CA · contact PI
The LIMIting AAA with meTformin (LIMIT) Trial$1,532,491
R61 · FY2020 · HL
Core B: Biostatistics and Data Management Core$291,766
P01 · FY2020 · CA · contact PI
BIOSTATISTICS$624,263
P30 · FY2011 · CA · contact PI
BIOSTATISTICS$614,633
P30 · FY2010 · CA · contact PI
BIOSTATISTICS$602,839
P30 · FY2009 · CA · contact PI
BIOSTATISTICS$612,827
P30 · FY2008 · CA · contact PI
Statistical Methods for Evaluation and Validation of Diagnostic Tests$240,757
R01 · FY2008 · EB · contact PI
BIOSTATISTICS$520,100
P30 · FY2007 · CA · contact PI
Statistical Methods for Evaluation and Validation of Diagnostic Tests$218,228
R01 · FY2007 · EB · contact PI
Statistical Methods for Evaluation and Validation of Diagnostic Tests$224,805
R01 · FY2006 · EB · contact PI
Statistical methods for utility of multiple tests$73,750
R03 · FY2003 · AR
Statistical methods for utility of multiple tests$73,750
R03 · FY2002 · AR
Statistical methods for utility of multiple tests$73,750
R03 · FY2001 · AR